Skip to content

The 95% Effective Dose of Remimazolam Tosilate for Induction of General Anesthesia in Adult Patients

The 95% Effective Dose of Remimazolam Tosilate for Induction of General Anesthesia in Adult Patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047868
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-06-27
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia

Interventions

Test group:injection with Remimazolam Tosilate

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. ASA I-II grade; aged 18 to 60 years; BMI18~28; gender is not limited; 2. Patients who plan to undergo general anesthesia on an elective basis.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Abnormal renal function (blood urea nitrogen >=1.5 ULN, serum creatinine greater than the upper limit of normal); hypovolemia, shock or coma; uncontrolled hypertension (systolic blood pressure>160mmHg, diastolic blood pressure>90mmHg) suffering from Mental system disease and long-term use of psychotropic drugs; 3. Cognitive dysfunction; allergic or contraindicated to benzodiazepines or their components; pregnant or lactating female patients; history of drug dependence; 4. Used other sedative drugs in the past week; participated in drug clinical trials as subjects in the past 3 months.

Design outcomes

Primary

MeasureTime frame
success rate of sedation;

Secondary

MeasureTime frame
blood pressure;Heart rate;mood;use of drug during induction;depthe of sedation;time;adverse reaction;Intraoperative awareness;degree of satisfaction;

Countries

China

Contacts

Public ContactXia Zhongyuan

Renmin Hospital of Wuhan University

xiazhongyuan2005@aliyun.com+86 13808628560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026